ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)
Clinical trial NCT05006885 · COMPLETED
Trial details
- NCT number
- NCT05006885
- Sponsor
- Altimmune, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-30
- Primary completion
- 2022-08-17
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.